Updated on 5 July 2012
"BiotechCorp is constantly seeking to validate and recognize companies such as ADT Biotech which bring a wealth of innovation, as well as research and development capabilities which benefit not just Malaysians but the global community," said Dr Mohd Nazlee Kamal, Chief Executive Officer, BiotechCorp. "Altona Diagnostic's global reputation and expertise in developing fast and accurate solutions for infectious disease detection, focusing on emerging pathogens, is admirable and we look forward to continuously support their activities as a BioNexus status company."
Dr Ulrich Spengler, founder of Altona DIAGNOSTICS, Germany, added, "As a pioneer in molecular diagnostics and the commercialization of real-time PCR, we look forward to working closely with Malaysian talent to make this technology more accessible to healthcare practitioners here in this region. Our collaborations with Malaysian institutions will be especially significant in global efforts such as our recently-announced strategic partnership with the Bernhard Nocht Institute for Tropical Medicine to develop a specimen bank dedicated to tropical and rare diseases. Malaysian expertise in this area would be invaluable and mutually beneficial exchanges of knowledge such as these bear great promise for the future."